Sonata (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Sonata drug offered from Pfizer Laboratories Div Pfizer Inc. This gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | zaleplon |
| SUBSTANCE NAME: | ZALEPLON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-08-13 |
| END MARKETING DATE: | 0000-00-00 |
Sonata HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sonata from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 1999-08-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60793-145_dcfb1511-dbf5-4346-9067-6e98cdab6473 |
| PRODUCT NDC: | 60793-145 |
| APPLICATION NUMBER: | NDA020859 |
Other ZALEPLON Pharmaceutical Manufacturers / Labelers:
